Mutation m.3395A > G in MT-ND1 leads to variable pathologic manifestations.

Area of Science:

• Mitochondrial Genetics
• Molecular Biology
• Biochemistry

Background:

• A specific mitochondrial DNA (mtDNA) mutation, m.3395A>G, alters the MT-ND1 gene product (p.MT-ND1) from tyrosine to cysteine at position 30.
• This mutation has been observed in patients with diverse conditions like deafness, diabetes, and cerebellar syndrome, but notably not Leber's hereditary optic neuropathy.
• Previous studies have not definitively established the pathogenicity of this m.3395A>G mutation.

Purpose of the Study:

• To investigate the pathogenicity of the isolated m.3395A>G mtDNA mutation.
• To assess the functional consequences of the mutation on mitochondrial bioenergetics.
• To elucidate the underlying mechanism of p.MT-ND1 dysfunction.

Main Methods:

• Construction of cybrid cell lines harboring the m.3395A>G mutation.
• Functional assessment of mitochondrial respiratory chain activity and Complex I.
• Analysis of Complex I quantity and assembly using structural and literature data.

Main Results:

• The m.3395A>G mutation significantly impairs mitochondrial respiratory chain function, specifically decreasing Complex I activity and quantity.
• The reduction in Complex I is linked to diminished p.MT-ND1 levels.
• Assembly of Complex I appears unaffected, as no subcomplexes were detected in mutant cybrids.

Conclusions:

• The m.3395A>G mutation is pathogenic, causing significant mitochondrial dysfunction.
• The mutation leads to degradation of p.MT-ND1, impacting Complex I function.
• This research offers new understanding into the pathophysiology of mitochondrial diseases linked to MT-ND1 mutations.